🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Precision gene- and immune-targeted therapies show impressive results in metastatic solid cancers. Time to move to newly diagnosed disease as we did in CML— once a fatal leukemia, now near normal life expectancy 🎯💡🎯 doi.org/10.1016/j.medj…

Yes! It should be a mistake for it not to be identical.

The ESMO - Eur. Oncology - Gynaecological Cancers Annual Congress 2025 titles are here. #LARVOL #CancerResearch #GynecologicCancer #CancerCare #ESMOGynae25 | LARVOL Connect with some of the top oncology voices on X: Matteo Lambertini, MD PhD | Mark Lewis, MD, FASCO | Vivek Subbiah, MD | Razelle Kurzrock, MD |

We’re often tempted to believe that diagnosing a recurrence earlier will improve outcomes. Clinical trials, however, suggest the opposite. We need new studies, with new tools (eg ctDNA) & implementation of new treatments. But we also need to inform pts adequately on this topic.

The DART trial represents the most significant advance in rare cancers, period. The Hope Foundation for Cancer Research DART has been, without doubt, one of the most brilliant jewels in the very heavy crown of SWOG Cancer Research Network clinical trials. DART was awarded “best trial” by National Cancer Institute for ample reasons, chief of

Inspiring session on precision oncology and truly patient-centric trials (N-of-1)! Honored to meet the incredible Razelle Kurzrock, MD. #AACR25

Wonderful precision medicine, rare cancer, n-of-1 AACR session with Drs Sewanti Limaye giving us the view from India and Young Chae talking about our DART National immunotherapy trial for rare cancers (NCI/SWOG)

Umut Disel— a phenomenal precision oncologist from Turkey and Marvin Hsieh, terrific second year medical student joined

Look whom I found at AACR. David Hong, Jordi Rodon, Phil Cohen, Filip Janku, Ignacio Garrido Laguna. They are now giants

Nice AACR dinner. Seeing collaborators/mentees from all over the world: Umut Disel (Turkey), Sewanti Limaye (India), Adam Wahida and Philip Jost (Germany), Philip Cohen (husband) (California), and Marvin Hsieh (Wisconsin)

In case you are wondering, the mentee who has been the most challenging is Philip Cohen.

Dr Chae gave a superb presentation

I discovered that Sewanti Limaye is not only a fantastic precision oncologist, she is also an absolutely terrific speaker. She gave us the precision oncology view from India at our session at AACR.

Our DART team. DART hits the target 🎯🎯Sandip Patel, PI; Young Chae, Translational PI; Early Therapeutics and Rare Cancers SWOG committee. 1000 sites; 53 cohorts, ~25 positive cohorts. NCCN guideline changes; NCI Director award; important—new nivo/ipi option for rare cancers!

Dr Lara Davis presents thorough update on the SWOG Early Therapeutics and Rare Cancer committee Sarcoma Working Group that she leads . They just had a new trial approved!!!

Just a reminder re best drug (name) ever

Okay. This photo in the SWOG Cancer Research Network meeting lobby totally made my day! It's the 25th anniversary of the The Hope Foundation for Cancer Research-hosted #YITC. Check out all the amazing folks that have been thru the course since Day 1. I spy Neeraj Agarwal, MD, FASCO, Parminder singh, H. Jack West, MD, FASCO, Syed A. Ahmad, Reshma Jagsi,

Look to Larvol for amazing data.

So proud of our ETRC group and SWOG. Making a difference for patients with rare and ultra-rare cancers! 🦓🦓🦓🦄🦄🦄

Look whom I found at SWOG—Drs Herbst and Pusztai— brilliant colleagues from our MD Anderson days. They are both at Yale now. Time flies